PAI-1 gain-of-function genotype, factors increasing PAI-1 levels, and airway obstruction: The GALA II Cohort
- PMID: 28543872
- PMCID: PMC5764093
- DOI: 10.1111/cea.12958
PAI-1 gain-of-function genotype, factors increasing PAI-1 levels, and airway obstruction: The GALA II Cohort
Abstract
Background: PAI-1 gain-of-function variants promote airway fibrosis and are associated with asthma and with worse lung function in subjects with asthma.
Objective: We sought to determine whether the association of a gain-of-function polymorphism in plasminogen activator inhibitor-1 (PAI-1) with airway obstruction is modified by asthma status, and whether any genotype effect persists after accounting for common exposures that increase PAI-1 level.
Methods: We studied 2070 Latino children (8-21y) with genotypic and pulmonary function data from the GALA II cohort. We estimated the relationship of the PAI-1 risk allele with FEV1/FVC by multivariate linear regression, stratified by asthma status. We examined the association of the polymorphism with asthma and airway obstruction within asthmatics via multivariate logistic regression. We replicated associations in the SAPPHIRE cohort of African Americans (n=1056). Secondary analysis included the effect of the at-risk polymorphism on postbronchodilator lung function.
Results: There was an interaction between asthma status and the PAI-1 polymorphism on FEV1 /FVC (P=.03). The gain-of-function variants, genotypes (AA/AG), were associated with lower FEV1 /FVC in subjects with asthma (β=-1.25, CI: -2.14,-0.35, P=.006), but not in controls. Subjects with asthma and the AA/AG genotypes had a 5% decrease in FEV1 /FVC (P<.001). In asthmatics, the risk genotype (AA/AG) was associated with a 39% increase in risk of clinically relevant airway obstruction (OR=1.39, CI: 1.01, 1.92, P=.04). These associations persisted after exclusion of factors that increase PAI-1 including tobacco exposure and obesity.
Conclusions and clinical relevance: The decrease in the FEV1 /FVC ratio associated with the risk genotype was modified by asthma status. The genotype increased the odds of airway obstruction by 75% within asthmatics only. As exposures known to increase PAI-1 levels did not mitigate this association, PAI-1 may contribute to airway obstruction in the context of chronic asthmatic airway inflammation.
Keywords: PAI-1; asthma; epidemiology; pediatrics.
© 2017 John Wiley & Sons Ltd.
Conflict of interest statement
References
-
- Demissie K, Ernst P, Hanley JA, Locher U, Menzies D, Becklake MR. Socioeconomic status and lung function among primary school children in Canada. American journal of respiratory and critical care medicine. 1996;153(2):719–23. - PubMed
-
- Ramsay SE, Whincup PH, Lennon LT, Morris RW, Wannamethee SG. Longitudinal associations of socioeconomic position in childhood and adulthood with decline in lung function over 20 years: results from a population-based cohort of British men. Thorax. 2011;66(12):1058–64. - PubMed
MeSH terms
Substances
Grants and funding
- R01 ES015794/ES/NIEHS NIH HHS/United States
- R25 CA113710/CA/NCI NIH HHS/United States
- R01 AI079139/AI/NIAID NIH HHS/United States
- R01 HL078885/HL/NHLBI NIH HHS/United States
- UL1 TR001422/TR/NCATS NIH HHS/United States
- U19 AI077439/AI/NIAID NIH HHS/United States
- 11SDG7590063/AHA/American Heart Association-American Stroke Association/United States
- R01 HL088133/HL/NHLBI NIH HHS/United States
- R01 HL118267/HL/NHLBI NIH HHS/United States
- K23 HL093023/HL/NHLBI NIH HHS/United States
- L32 MD000659/MD/NIMHD NIH HHS/United States
- R01 HL104608/HL/NHLBI NIH HHS/United States
- K23 AI110731/AI/NIAID NIH HHS/United States
- T32 CA113710/CA/NCI NIH HHS/United States
- P60 MD006902/MD/NIMHD NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous
